MedTrace Logo

Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)

NCT01254799 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2011-11-28

No results posted yet for this study

Summary

This study aims to test the effect of Doxycycline in treatment of uterine bleeding during the use of injectable contraception that contains one hormone "progesterone only".

Conditions

  • Uterine Hemorrhage

Interventions

DRUG

Doxycycline

100 mg Doxycycline capsules twice daily for 5 days

DRUG

Placebo

Placebo capsules twice daily for 5 days

Sponsors & Collaborators

  • Omar Mamdouh Shaaban

    lead OTHER

Principal Investigators

  • Hany Abdel-Aleem, MD · Assiut University

  • Omar M Shaaban, MD · Assiut University

  • Mahmoud Abdel=Aleem, MD · Assiut University

  • Gehian N Fetih, PH.D · Faculty of Pharmacy, Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-09-30
Completion
2011-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01254799 on ClinicalTrials.gov